https://ee.prisysbiotech.com/ Mitte - Inimene Primaat Teadusuuringud Platvorm & CRO | PRISYS Biotehnoloogia https://ee.prisysbiotech.com/uploads/39406/logo.png https://ee.prisysbiotech.com/nhp-pharmacology/ NHP farmakoloogia https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://ee.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://ee.prisysbiotech.com/translation-research/ Tõlkeuuringud https://ee.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://ee.prisysbiotech.com/safety-evaluation/ Ohutuse hindamine https://ee.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://ee.prisysbiotech.com/biosafety-research/ Bioohutuse uuringud https://ee.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://ee.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://ee.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://ee.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ee.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://ee.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://ee.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://ee.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://ee.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://ee.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://ee.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://ee.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://ee.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://ee.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://ee.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://ee.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://ee.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://ee.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://ee.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://ee.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://ee.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://ee.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://ee.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://ee.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://ee.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://ee.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://ee.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://ee.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://ee.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://ee.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://ee.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://ee.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://ee.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://ee.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://ee.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://ee.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://ee.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://ee.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://ee.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://ee.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://ee.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://ee.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://ee.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://ee.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://ee.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://ee.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://ee.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://ee.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://ee.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://ee.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://ee.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://ee.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://ee.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://ee.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://ee.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://ee.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://ee.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://ee.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://ee.prisysbiotech.com/pk-pd-adme/adme.html ADME https://ee.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://ee.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://ee.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://ee.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://ee.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://ee.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://ee.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://ee.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://ee.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://ee.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://ee.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://ee.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://ee.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://ee.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://ee.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://ee.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://ee.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://ee.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://ee.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://ee.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://ee.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://ee.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://ee.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://ee.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://ee.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://ee.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://ee.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://ee.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://ee.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://ee.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://ee.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://ee.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://ee.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://ee.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://ee.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://ee.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://ee.prisysbiotech.com/translation-research/clinical-imaging.html Kliiniline pildistamine https://ee.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Kliiniline pildistamine https://ee.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://ee.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://ee.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://ee.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://ee.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://ee.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://ee.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://ee.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://ee.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://ee.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://ee.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://ee.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://ee.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://ee.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://ee.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://ee.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://ee.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://ee.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://ee.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://ee.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://ee.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://ee.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://ee.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://ee.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://ee.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://ee.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://ee.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://ee.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2. tüüpi diabeedi mudel https://ee.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png 2. tüüpi diabeedi mudel https://ee.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://ee.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://ee.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://ee.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://ee.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://ee.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://ee.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://ee.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://ee.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://ee.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://ee.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://ee.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://ee.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://ee.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://ee.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://ee.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://ee.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://ee.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://ee.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://ee.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://ee.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://ee.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://ee.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://ee.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://ee.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://ee.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://ee.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://ee.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://ee.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://ee.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://ee.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://ee.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://ee.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://ee.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://ee.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://ee.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://ee.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://ee.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://ee.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://ee.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://ee.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://ee.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://ee.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://ee.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://ee.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://ee.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://ee.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://ee.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://ee.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://ee.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://ee.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003086995235840.html Molekulaarkujutised NHP mudelites translatiivse ravimiarenduse jaoks https://ee.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://ee.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17968232084595712.html NHP BehaviorAtlase veebiseminar|3D NHP käitumise jälgimine ravimite arendamiseks https://ee.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://ee.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724161928651776.html 2025. aasta kokkuvõte: kuidas Prisys defineerib ümber tõlkekindluse NHP-uuringutes https://ee.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://ee.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17552981673419776.html NHP - põhineb farmakoloogias ja farmakodünaamilised teenused|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ee.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17529382179972096.html Tutvuge eelseisva EL Roadshow: septembri 2025. aasta Prisys Biotechiga https://ee.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://ee.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17446955203650560.html Prisys Biotech-2025. aasta keskpaiga ülevaade https://ee.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ee.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17245161125225472.html Tutvuge eelseisva USA-roadshow vanglatega märtsis 2025 https://ee.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ee.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84025137.html PRISYSi aastaaruanne 2024: NHP mudelite ja prekliiniliste uuringute edendamine https://ee.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://ee.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77705064.html Prisys Biotech 2024. aasta 2. kvartali infoleht – täiustatud prekliiniline uurimis- ja arendustegevus kesknärvisüsteemi teraapia jaoks PRISYSi ristreaktiivsete mudelitega https://ee.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://ee.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028052788438016.html Miks loommudelid ravimite väljatöötamisel õnnestuvad või ebaõnnestuvad? https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021124912309248.html Kvantitatiivne PET-i sihtmärk kaasamine NHP-desse kesknärvisüsteemi ravimite jaoks https://ee.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://ee.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18014992917144576.html Videost andmeteni: 3D AI jälgimine NHP käitumise jaoks https://ee.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://ee.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015069370491904.html PET-i biojaotuskujutis{0}}ahvilistel https://ee.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://ee.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003087054529536.html PBPK vs. Sektsioonilised mudelid: miks PBPK on oluline? https://ee.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://ee.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993012763403264.html Veebiseminari kokkuvõte: NHP translatiivse uurimistöö edendamine digitaalse käitumise fenotüüpimise kaudu https://ee.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://ee.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990258659795968.html PK biomarkerid prekliinilises ravimiarenduses|Kokkupuude – reaktsioon ja PK/PD https://ee.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://ee.prisysbiotech.com/news/behavior-in-rhesus-17983339306951680.html Spontaanne enese{0}}vigastuslik käitumine reesusmakaakide puhul: NS-i translatiivne mudel neuropsühhiaatriliste ravimite väljatöötamiseks https://ee.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://ee.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17983338549617664.html MIDD ja NHP tõhususe mudelid translatiivses ravimiarenduses https://ee.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://ee.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17973643602994176.html AI-Toitega 3D NHP käitumisanalüüs|Markerita käitumuslik fenotüüpimine https://ee.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://ee.prisysbiotech.com/news/webinar-nhp-behavioratlas-17973643385365504.html Ülemaailmne veebiseminar|Kompleksse NHP käitumise kvantifitseerimine: NHP käitumisatlase tutvustamine kõrge{0}}3D-käitumusliku fenotüüpimise jaoks https://ee.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://ee.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17968232496260096.html AI-Toimitud NHP käitumise analüüs prekliinilise ravimiarenduse jaoks|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://ee.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17973643674215424.html Millal tutvustada NHP uuringuid autoimmuunsete ravimite väljatöötamisel https://ee.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://ee.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17973643362165760.html NHP IBD mudelid: mida reesusmakaakide krooniline enterokoliit meile translatiivse soolepõletiku kohta õpetab https://ee.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://ee.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17973643111195648.html MRI-Juhitud AAV-i manustamine NHP ajumudelites kesknärvisüsteemi geeniteraapia jaoks https://ee.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://ee.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17973643211088896.html Miks on positiivse kontrolliga ravimid autoimmuunhaiguste mudelites olulised|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://ee.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17973642919601152.html Algtaseme ADA sõeluuring Washed{0}}Ahvidel prekliiniliste bioloogiliste uuringute jaoks https://ee.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://ee.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17968231848879104.html Valumehhanismid: UVB päikesepõletuse mudel on oluline tõlkevahend https://ee.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://ee.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17968231985914880.html NHP mudelid emade suure{0}}rasvasisaldusega dieedi ja laste rasvumise programmide kohta https://ee.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://ee.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17938567618077696.html Kliinilise patoloogia tõlgendamine koertel ja ahvilistel prekliinilistes uuringutes https://ee.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://ee.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17938567594009600.html Molekulaarse pildistamise biomarkerid: translatiivsete uuringute ja ravimiarenduse edendamine https://ee.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://ee.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17938567674979328.html Mis on mittelineaarne farmakokineetika? Mehhanismid, omadused ja mõju ravimite väljatöötamisele https://ee.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://ee.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17938567416849408.html Miks on NHP molekulaarne pildistamine translatiivsete PET-uuringute jaoks ülioluline? https://ee.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://ee.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17938567710041088.html Mis on molekulaarne pildistamine ja miks on see ravimite arendamisel oluline? https://ee.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://ee.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17938567554622464.html NHP radionukliidide bioloogilise jaotumise uuringud: molekulaarne pildistamine ravimite translatiivseks arendamiseks https://ee.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://ee.prisysbiotech.com/news/nhp-heart-failure-model-17938567266034688.html NHP südamepuudulikkuse mudel toetab telomeeride taastamise geeniteraapia translatsiooniuuringuid https://ee.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://ee.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17938567298933760.html Kuidas DSA ja CTA-kuvamine parandavad kardiovaskulaarsete ravimite ohutuse hindamist https://ee.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://ee.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17938567464756224.html NHP arteriovenoosse šundi tromboosi mudel Cynomolguse ahvidel translatiivse antitrombootilise ravimi hindamiseks https://ee.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://ee.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888348782699520.html Farmakokineetilised andmed kui translatiivne biomarker https://ee.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://ee.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888348758172672.html Kopsufibroosi mitte-ahvilised mudelid: tõlketäpsuse suurendamine hingamisteede ravimite väljatöötamisel https://ee.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://ee.prisysbiotech.com/news/nhp-models-translational-drug-development-17888349024494592.html Miks ravimiarendus sõltub üha enam NHP mudelitest|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://ee.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888348902302720.html PK andmed farmakodünaamilise biomarkerina: ravimite translatsiooni arendamise edendamine kvantitatiivse farmakoloogia kaudu https://ee.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://ee.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17852603139007488.html Mitte{0}}GLP farmakoloogiauuringud regulatiivseks esitamiseks: andmete terviklikkus ja laborinõuded https://ee.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://ee.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17852603187127296.html Mittekliiniliste farmakokineetiliste uuringute strateegiline kavandamine: ADME profiilide koostamisest translatiivsete otsuste tegemiseni{0}} https://ee.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://ee.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17852603465769984.html NHP AV-Sundi tromboosi mudel ravimiohutuse hindamiseks|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://ee.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17852603184194560.html Mis on mittelineaarne farmakokineetika? Mehhanismid ja translatiivne PK hindamine|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://ee.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17852603635770368.html Prisys Biotech toetab UX-i -GIP001 IND-kinnitust FDA ja CDE poolt|NHP kesknärvisüsteemi kohaletoimetamise platvorm https://img01.v15cdn.com/gallery/4x3/157.webp https://ee.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17852603279123456.html In vivo immuunrakkude jälgimine ja PET-märgistuse väljatöötamine NHP mudelites|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://ee.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17852603675337728.html Dopamiini transporter PET-kujutis NHP mudelites|Kesknärvisüsteemi pildistamine|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://ee.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17852603205248000.html PET/CT biojaotus NHP mudelites kesknärvisüsteemi ravimite manustamiseks|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://ee.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17852603046192128.html Suur-loomade radiomärgistamise ja in vivo pildistamise platvorm ravimite translatiivseks arendamiseks https://ee.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://ee.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17852603038524416.html Miks toetub ravimiarendus üha enam NHP mudelitele: primaatide oluline roll translatsioonimeditsiinis|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://ee.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17852603067425792.html IPF ravimiarenduse väljakutsed ja lahendused|NHP mudelid koos CT-kujutise ja PFT-ga https://ee.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://ee.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17852603001005056.html AI Markerless NHP 3D käitumise analüüsisüsteem prekliiniliste uuringute jaoks https://ee.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://ee.prisysbiotech.com/news/evaluating-dmpk-properties-17852603174528000.html Kandidaatühendite DMPK omaduste hindamine ravimite varajases avastamises|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://ee.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17852600064992256.html MRI-Juhitud kesknärvisüsteemi kohaletoimetamine NHP mudelites|Translatiivne IMRI ja CED platvorm https://ee.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://ee.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17852592418022400.html NHP kesknärvisüsteemi bioloogilise jaotumise uuringud|Intratekaalne RNA kohaletoimetamine|PRISYS Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://ee.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17852592689275904.html Translatiivne PK/PD raamistik: Cynomolgus Monkey to Human Dose Prediction|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://ee.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724162071241728.html Kui valu muutub mälestuseks: kroonilise valu emotsionaalsed tegurid ja NHP mudeli eelis|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://ee.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724161861116928.html Mitme-lõpppunkti valu hindamine: valuvaigistite väljatöötamise tulevik https://ee.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://ee.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724161961436160.html Miks nii paljud valuvaigistid prekliinilistes uuringutes ebaõnnestuvad? Vastus peitub selles, kuidas me valu mõõdame https://ee.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://ee.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724162059019264.html Vereproovide võtmise ajapunktide kavandamine farmakokineetilistes (PK) uuringutes|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://ee.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724162175984640.html PK statistika: mitte{0}}kambrianalüüsi (NCA) parameetrid ja prekliinilised rakendused https://ee.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://ee.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724161847256064.html Miks on ahviliste mudelid kesknärvisüsteemi oligonukleotiidravi jaoks kriitilise tähtsusega https://ee.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://ee.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724161871324160.html Kusihappe metabolism inimestel vs ahvid: translatiivsed tagajärjed ravimite väljatöötamisele https://ee.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://ee.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724161810686976.html Mitte-primaadi MASH-seotud maksafibroosi mudel|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://ee.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724163091784704.html Miks on IMRI{0}}Juhitud ajuravimite manustamine NHP uuringute täpseks sihtimiseks hädavajalik https://ee.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://ee.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674422501975040.html AI-Juhitud markerita NHP 3D käitumisanalüüsi süsteem|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://ee.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674422643631104.html LPS-Indutseeritud ägeda kopsupõletiku (ALI) NHP mudel|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://ee.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674422551585792.html HDM+SEB-Indutseeritud atoopilise dermatiidi (AtD) mudel Cynomolgus Monkeys'is https://ee.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://ee.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674422724666368.html Ühe- kuni mitme-kambriga PK mudelite selgitus|NHP farmakokineetika|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://ee.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674422627132416.html Kuidas valida usaldusväärset prekliinilist CRO-d|Biotehnoloogiaettevõtete põhikriteeriumid|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://ee.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674422398804992.html Translatiivne CAR-T hindamine: in vitro ekspertiis ja NHP-uuringute tugi – Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://ee.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674422442468352.html Miks enam kui 90% kesknärvisüsteemi ravimite kandidaatidest ebaõnnestub kliinilistes uuringutes? https://ee.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://ee.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674422616138752.html Parkinsoni tõve prekliinilised mudelid: juhend neurotoksiinide, geneetiliste ja NHP mudelite valimiseks|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://ee.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674422522717184.html Kõrge-täpse ravimite kohaletoimetamise ja tehisintellektiga- juhitud NHP tõlkeplatvormid https://ee.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://ee.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625029182792704.html Th17-põhised NHP immunoloogiamudelid|Translatiivsed autoimmuunuuringud Prisys Biotechis https://ee.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://ee.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625030143632384.html AI-põhine NHP BehaviorAtlas® süsteem|3D käitumisanalüüsi platvorm|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://ee.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625028477445120.html RFP mall NHP uuringute jaoks|Prekliiniliste uuringute tõhususe kiirendamine https://ee.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://ee.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625028322173952.html Cold Allodynia valu mudel Cynomolgus Monkeys|Prisys Biotechnologies https://ee.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://ee.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625028517635072.html MRI-Juhitud intratserebraalne ravimite kohaletoimetamise platvorm|Prisys Biotechi kesknärvisüsteemi uurimine https://ee.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://ee.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625028684555264.html NHP hingamisteede haiguste mudelid ja hingamisteede ravimite kohaletoimetamise platvorm|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://ee.prisysbiotech.com/news/nhp-renal-biopsy-17625028674954240.html NHP neerubiopsia platvormi ja neeruhaiguste mudelid|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/276.webp https://ee.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625028519175168.html PK uuringud ja sihipärane ravimite tarnimine|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://ee.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625028458570752.html Prisys Biotechnologiesi NHP-uuringute ja tehisintellekti{0}}põhine käitumisanalüüsi platvorm https://ee.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://ee.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625028331447296.html Ninast-ajusse-ajusse (N2B) kohaletoimetamise tehnoloogia kesknärvisüsteemi uuringute jaoks|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://ee.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625028285391872.html SHR-2004: läbimurre VTE ennetamises munasarjavähiga patsientidel – Prisys Biotechi edulugu https://ee.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://ee.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17537979712021504.html Cynomolgus & Reesus Monkey Models|Prisys Biotechi prekliiniline CRO https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17529382039561216.html Idiopaatiline kopsufibroos (IPF) NHP mudel|Prisys Biotech prekliiniline cro https://ee.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://ee.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17529382161409024.html Cynomolgus Monkey Bioloogilise leviku uuringud|Prisys Biotechi prekliiniline CRO https://ee.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://ee.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17529382185067520.html Prisys Biotech NHP hematoloogia ja insuldiuuringute mudelid https://ee.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://ee.prisysbiotech.com/news/the-importance-of-administration-volume-17529382055568384.html Manustamismahu tähtsus prekliinilistes uuringutes|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://ee.prisysbiotech.com/news/brain-targeted-drug-delivery-17529381962753024.html Aju - sihitud ravimi kohaletoimetamine|Prisys Biotech prekliinilise NHP uurimistöö https://ee.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://ee.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17529382315582464.html ADC ravimiarendus|Translatiivne PK/PD raamistik prekliinilistes NHP uuringutes https://ee.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://ee.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17494154411566080.html NHP valumudelid ravimite translatiivseks avastamiseks|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://ee.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17494154505839616.html Seerum vs. Plasma: optimaalse maatriksi valimine prekliiniliseks bioanalüüsiks https://ee.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://ee.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17494154254345216.html Prekliinilised annustamisjuhised: IV ja PO maht, PH ja osmolaarsus täpse PK jaoks NHP-de ja muude liikide puhul https://ee.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://ee.prisysbiotech.com/news/nhp-copd-model-17494154233586688.html KOK -i parimad uurimismudelid ja hingamisteede platvorm tipptasemel Prisys https://ee.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://ee.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17494154307003392.html NHP äge hemorraagiamudel: ülioluline vahend uudse hematoloogia ravimite arengu kiirendamiseks https://ee.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://ee.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17494154257703936.html Pruriituse uuringud: Prisys Biotechi IL-31-indutseeritud NHP mudel, et hinnata ravimeetoditevastaseid ravimeid https://ee.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://ee.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17446955867137024.html Juhend anti{0}}ravimite antikehade (ADA) hindamiseks https://img01.v15cdn.com/gallery/4x3/148.webp https://ee.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17446955374404608.html Hingamisteede ravi: Prisys Biotechi integreeritud NHP platvorm prekliiniliste uuringute jaoks https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17446955317978112.html NHP valumudelid: valuvaigistava ravimi arengu kiirendamine Prisys Biotechis https://ee.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://ee.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17446955050738688.html NHP mudeliplatvormid ravimite arengu toetamiseks keerukate haiguste korral https://ee.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ee.prisysbiotech.com/news/key-considerations-for-dosing-volume-17446955370193920.html Peamised kaalutlused doseerimismahu, PH ja koostise osas loommudelites https://ee.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://ee.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17446955248722944.html Insenertehnilised eksosoomid: pöördeline ravimite kohaletoimetamine kesknärvisüsteemi häirete korral – Prisys Biotechi prekliinilised ülevaated https://img01.v15cdn.com/gallery/4x3/300.webp https://ee.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17446955187872768.html Loomaliikide valimise juhtpõhimõtted nukleiinhapete ravimite toksikoloogia uuringutes https://img01.v15cdn.com/gallery/4x3/148.webp https://ee.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17446955388019712.html Prisys Biotechi DSA ja IMRI hematoloogiliste, vaskulaarsete ja neeruhaiguste uuringute jaoks https://ee.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://ee.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17446955047789568.html Cynomolguse ahvide valumudelid: läbimurdeliste ioonkanalite teraapiate tõukeuuringute toetamine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17446955991852032.html Atoopilise dermatiidi uurimine: Prisys Biotechi mitteinimese primaatide (NHP) mudel https://ee.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://ee.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17446955191231488.html Prisys Biotechi NHP atoopilise dermatiidi mudel ravimivastase arengu jaoks https://ee.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://ee.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17383757811885056.html Loomuuringute kavandamine: peamised kaalutlused prekliiniliste uuringute õnnestumiseks https://img01.v15cdn.com/gallery/4x3/300.webp https://ee.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17383757475062784.html Atoopiline dermatiit: kuidas Cynomolgus Monkey mudelid edendavad täpset terapeutilisi ravimeid https://ee.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://ee.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17383757576823808.html Astmauuringud: miks on ahviliste mudelid uudsete ravimite väljatöötamisel keskse tähtsusega https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17383757397320704.html Antisenss-oligonukleotiidi (ASO) farmakokineetika mõistmine: imendumise ja jaotumise peamised tegurid https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17383757795468288.html NHP inhalatsiooniuuringud bioloogia jaoks: PRISYSi spetsialiseeritud prekliinilised CRO teenused https://img01.v15cdn.com/gallery/4x3/300.webp https://ee.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17383757533471744.html Täiustatud prekliinilised inhalatsiooniuuringud: tehnilised võimalused ja teadmised ettevõttes Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://ee.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17383757471867904.html Farmakokineetika mõistmine (PK): peamised parameetrid ja rakendused ravimite väljatöötamisel https://ee.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://ee.prisysbiotech.com/news/intracerebroventricular-icv-injection-17383757631759360.html Intratserebroventrikulaarne (ICV) süstimine: kesknärvisüsteemi täpne manustamine prekliiniliste uuringute jaoks https://ee.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://ee.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17383757409002496.html Intratserebraalne (ICM) süstimine: kesknärvisüsteemi teraapia täpne sihtimine – prekliinilised kaalutlused https://img01.v15cdn.com/gallery/4x3/148.webp https://ee.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17383757546988544.html Intratekaalne (IT) süstimine: otsene kesknärvisüsteemi manustamisviis kõrgtehnoloogiliste ravimeetodite jaoks – prekliinilised kaalutlused https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17383757396501504.html Parkinsoni tõve uurimise edendamine NHP mudeli abil https://img01.v15cdn.com/gallery/4x3/300.webp https://ee.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17383757506716672.html Prekliinilised PK/PD uuringud ja NHP mudelid ravimite väljatöötamiseks|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://ee.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17301356910781440.html Interleukiin-31 (IL-31) sihtimine: uus piir autoimmuunhaiguste ravimite väljatöötamisel – Prisys Biotechi NHP mudelid prekliiniliste uuringute jaoks https://ee.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://ee.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17296354178016256.html Mittekliiniline immunotoksilisuse hindamine: strateegia, peamised kaalutlused ja meetodi valik https://img01.v15cdn.com/gallery/4x3/232.webp https://ee.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17296353826300928.html Mikroobide testimine ja selle mõju mitte{0}}ahvilistele DMPK prekliinilistes uuringutes https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17296353954735104.html Cynomolgus ahvi endometrioosi mudel terapeutiliste uuringute edendamiseks https://ee.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://ee.prisysbiotech.com/news/membranous-nephropathy-model-17296353715151872.html Membraanse nefropaatia (MN) ravimite arendamine: Prisys Biotechi Cynomolgus Monkey mudeliplatvorm https://img01.v15cdn.com/gallery/4x3/148.webp https://ee.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17296354071618560.html Inhaleeritavate ravimite farmakokineetika: Paradigma nihe süsteemselt kokkupuutelt pulmonaarsele kokkupuutele https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/animal-models-for-womens-health-17296353568416768.html Prisys Biotech: naiste terviseteraapia loomamudelid https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17296354120573952.html Maailma rasvumise päev|Prisys Biotech NHP metaboolne mudelid: järgmise põlvkonna rasvumisvastaste ravimeetodite väljatöötamine https://ee.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://ee.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17296353763107840.html Prisys Biotechi Cynomolgus Monkey Psoriaasi mudel: prekliinilise farmakodünaamika hindamise edendamine https://ee.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://ee.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17296353575199744.html Farmakokineetika ja farmakodünaamika integreerimine ravimite väljatöötamisel https://ee.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://ee.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888348840289280.html Nõudmisel{0}}veebiseminar|Täppissild: MRI{1}}CED ja tõlgitavad NHP mudelid kesknärvisüsteemi ravimite kohaletoimetamiseks https://ee.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://ee.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17296354034230272.html Mida kontseptsiooni tõendamine (PoC) ravimiarenduses tegelikult kinnitab? https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17296353446421504.html Loomamudelid|Väljakutsed ja rakendused valumudeli väljatöötamisel https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17296354069029888.html Mittekliinilised farmakodünaamilised uuringud https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17245161348195328.html Ideaalse ahvilise valimine toksikoloogiauuringuteks: makaakid, reesusmakaagid ja marmosett https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81136554.html Parkinsoni tõve sihipärane ravi: läbimurre{0}}reaalajas MRI-juhitud tüvirakkude siirdamine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17296389757051904.html Süsteemne erütematoosluupus (SLE) ja loommudelite roll terapeutilises arengus https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17296389816329216.html Reumatoidartriidi (RA) mitteinimene primaatide mudel https://ee.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://ee.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17296389706245120.html Loomaaju stereotaktilised instrumendid, mis põhinevad 3D-koordinaatsüsteemidel https://ee.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://ee.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17296354007688192.html In vivo testimise loommudelid (1): kehtestamine ja klassifitseerimine https://img01.v15cdn.com/gallery/4x3/148.webp https://ee.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84025133.html Bioloogia ajusse sisenemise potentsiaalsete teede uurimine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84025139.html Reumatoidartriidi (RA) uuringute edendamine ahviliste mudelitega https://ee.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://ee.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84025138.html Atoopilise dermatiidi ravimite tõhususe loommudelite uurimine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84025134.html Loommudelite kriitiline roll inimhaiguste uurimisel https://ee.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://ee.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84025135.html Parkini geenipuuduse ahvi mudel paljastab Parkinsoni tõve uued mehhanismid ja terapeutilised eesmärgid https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84025136.html Mittekliiniliste ravimite väljatöötamise juhend: ägeda, alaägeda, subkroonilise ja kroonilise üldise toksilisuse uuringud https://ee.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://ee.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84025132.html Uuenduslik nina kaudu ajusse (N2B) ravimite manustamine: vere-aju barjääri möödaminek https://ee.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://ee.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84025131.html Minisigade kui mittekliinilise suurloomaliigi võimalused ja väljakutsed https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83030392.html Ajuhaiguste ravimite manustamise strateegiad https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83017881.html Reaalajas{0}}operatiivne MRI-navigeerimine: AADC puudulikkuse esimese geeniteraapia FDA heakskiidu toetamine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83029602.html Silmatilkade silmatoksilisuse uuringud: ravimite kokkupuude ja ohutuse hindamine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82710094.html Prisys Biotech loob Cynomolgus Monkey psoriaasi mudeli, et kiirendada ravimite väljatöötamist https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82710099.html Prisys Biotechi põhjalikud mitte-{0}}primaatide mudelid neeruhaiguste uurimiseks https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82710097.html Antikehade{0}}ravikonjugaatide (ADC) põhjalik prekliiniline ohutuse hindamine ahvilistel https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82710092.html Antikehade{0}}ravimikonjugaatide (ADC) farmakokineetika hindamine ahvilistel https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82710109.html ADC-de farmakodünaamika hindamine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82710093.html ADC ravimite DMPK mõistmine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82710095.html Edusammud nukleiinhapperavimite ja Prisys Biotechi uurimisvõimaluste arendamisel https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395256.html Edusammud mRNA kopsude manustamissüsteemides ja Prisys biotechi uuenduslikes teenustes https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82710127.html Miks anti 2024. aasta Nobeli füsioloogia- või meditsiiniauhind neile kahele teadlasele, kes uurisid mikroRNA-d? https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82710096.html Kesknärvisüsteemi (KNS) ravimite farmakokineetilised (PK) kaalutlused https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656501.html Kesknärvisüsteemi uuringute edusammud: Prisys Biotechi MRI{0}}ühilduv ajusüstesüsteem ja CED-tehnoloogia https://ee.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://ee.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81136548.html Verejooksu ja hüübimise terapeutiliste uuenduste edendamine Cynomolgus Monkey MCAO mudeliga https://ee.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://ee.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81136547.html DMPK kesknärvisüsteemi (KNS) ravimite hindamine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/animal-models-of-human-diseases-81136545.html Inimhaiguste loommudelid https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81136546.html Valu hindamise uuendused: AI{0}}põhine käitumisanalüüs https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/china-experimental-monkey-industry-81136549.html Hiina eksperimentaalse ahvitööstuse ajalugu, hetkeseis, väljakutsed ja võimalused https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/human-disease-animal-models-81136550.html Inimhaiguste loomamudelid: oluline vahend biomeditsiiniliste uuringute edendamiseks https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81136553.html Prekliinilise farmakodünaamika tähtsus ravimite väljatöötamisel|Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://ee.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81136907.html Intranasaalne manustamine loomuuringutes https://ee.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://ee.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79417113.html Revolutsiooniline kesknärvisüsteemi ravimite väljatöötamine: PRISYS Biotech tutvustab IMRI tehnoloogiat https://ee.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://ee.prisysbiotech.com/news/convection-enhanced-delivery-81136544.html Täppismeditsiini arendamine: konvektsioon{0}}täiustatud kohaletoimetamise (CED) tehnoloogia, autor Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://ee.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81136552.html Cynomolgus Monkey Chronic Kidney Disease (CKD) Prisys Biotechi mudel https://ee.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://ee.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79533573.html Ravimite silma manustamise mittekliiniline ohutuse hindamine, kasutades Cynomolgus Macaques https://ee.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://ee.prisysbiotech.com/news/compartment-pk-model-81136555.html Sektsioonide ja mitte{0}}kambrite mudelite mõistmine farmakokineetikas https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81136543.html Täiustatud kesknärvisüsteemi kohaletoimetamise tehnikad Cynomolgus ahvidel: oligonukleotiidravimite väljatöötamise kiirendamine https://ee.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://ee.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79533569.html Ahviliste kasutamise vähendamine mittekliinilistes ohutushinnangutes: FDA ja tööstuse väljavaated https://ee.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://ee.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79533599.html LNP{0}}põhiste geeniteraapia ravimite LCMS-i prekliiniline bioanalüüs https://ee.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://ee.prisysbiotech.com/news/mrna-based-therapies-past-79533593.html MRNA{0}}põhised teraapiad: minevik https://ee.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://ee.prisysbiotech.com/news/pk-strategies-of-pdc-79533553.html Peptiidide{0}}ravimikonjugaatide (PDC) farmakokineetilised uuringustrateegiad https://ee.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://ee.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79533576.html AAV roll geeniteraapias: immuunvastused ja toksilisus https://ee.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://ee.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79533572.html Optimeeritud mittekliinilise immunogeensuse hindamise strateegiad https://ee.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://ee.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79533591.html Geeniteraapia farmakodünaamiline (PD) hindamine https://ee.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://ee.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79533588.html Oligonukleotiidravimite farmakokineetika ja bioanalüüs-(1) https://ee.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://ee.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79533603.html Oligonukleotiidravimite farmakokineetika ja bioanalüüs: imendumise ja plasma farmakokineetika (PK) omadused https://ee.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://ee.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79533596.html Oligonukleotiidravimite immunogeensuse tegurid https://ee.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://ee.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79533608.html MRNA: võimas ja mitmekülgne tööriist haigustega võitlemiseks-Prisys-Biotech https://ee.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://ee.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79533587.html Hiina teadlased pakuvad uusi strateegiaid Parkinsoni tõve põhisümptomite ümberpööramiseks https://ee.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://ee.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79533586.html Prisys Biotechnology: uudsed lipiidide nanoosakesed MRNA kohaletoimetamiseks primaatidele https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79535902.html Translatiivse meditsiini uuringute tähtsus alusuuringutest kliiniliste uuringuteni https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79533609.html WOE analüüsis arvesse võetud peamised tegurid https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79535903.html Kuidas toimetada bioloogilisi aineid ajju? https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79533594.html Kuidas ravimid meie kehas liiguvad ja muutuvad: lühike sissejuhatus farmakokineetikasse https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79535900.html Kuidas uusi ravimeid kiiremini ja ohutumalt välja töötada: DMPK prekliiniliste uuringute juhend https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79535901.html Laboratoorsete ahvide rühmamajutamise juhised https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79533606.html Eksperimentaalsete ahvide oluline roll teadusuuringute edendamisel https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79533607.html Macaca Fascicularis'e (Cynomolgus Monkey) mõistmine: peamised omadused ja panus biomeditsiiniuuringutesse https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79533589.html Revolutsiooniline metaboolsete haiguste ravi: edusammud ja väljakutsed peptiidiravimite väljatöötamisel https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79533582.html Kuidas hinnata nahatoodete ohutust enne kliinilisi uuringuid? https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79533600.html Eksperimentaalsete ahvide oluline roll uuenduslikul ravimiarendusel: ülevaade ettevõttest https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79533598.html Maksatoksilisus kui SiRNA ravimite peamine probleem: põhjaliku analüüsi sihtspetsiifilisus: SiRNA kahe{0}}teraga mõõk https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79533581.html SiRNA-ravi edendamine: ravimite väljatöötamise väljakutsete ületamine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79533578.html Lipiidide nanoosakestel põhinevate geeniravimite kasutusvõimalused https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79533590.html Põhipunktid alaealiste loomade mittekliiniliste uuringute{0}}strateegiate väljatöötamisel https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79533585.html Ülevaade ahviliste sensoorsetest ja käitumisomadustest{0}} https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79533597.html Mittekliiniliste uuringute hindamise küsimused ja vastused https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/significance-principles-and-requirements-of-79533611.html Farmakoloogia ohutusuuringute tähtsus, põhimõtted ja nõuded https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79533584.html Kuidas hinnata prekliinilist farmakoloogilist efektiivsust? https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79533574.html Mõtisklused mitte-kliinilise farmakoloogia uuringute ja mittealkohoolse steatohepatiidi (NASH){1}}ravimite terapeutiliste ravimite hindamise kohta https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79533571.html Kesknärvisüsteemi ja CGT-uuringute edendamine: Prisysi biotehnoloogiad https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79533575.html Ahviliste tserebrospinaalvedeliku kogumise juhised- https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79533580.html Kaalutlused ahviliste (NHP) ja koerte kliinilise patoloogia andmete tõlgendamisel{0}} https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79533567.html ​​​​Kesknärvisüsteemi ohutuse hindamise integreerimine üldistesse toksikoloogiauuringutesse https://ee.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://ee.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79533601.html Kuidas läbi viia ADC-de prekliinilise farmakoloogia/toksikoloogia hindamist? https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79533583.html ADME ülevaated oligonukleotiidravimite jaoks (1) - Imendumine, jaotumine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79533602.html ADME ülevaated oligonukleotiidravimite kohta (2) - Metabolism ja eritumine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79533579.html Prekliinilised loomuuringud (1) - Loomaliigid https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79533570.html Kliinilise patoloogia andmete tõlgendamise väljakutsed ja strateegiad koerte ja ahviliste prekliinilistes uuringutes https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79533610.html Prekliinilised loomuuringud (2) - Manustamisviisid ja -mahud https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/mrna-based-therapies-present-79533604.html MRNA{0}}põhised ravimeetodid: praegu https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79533605.html MRNA{0}}põhised ravimeetodid: tulevik ja väljakutsed https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79533595.html Geeniteraapia bioloogilise analüüsi lühitutvustus https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79417114.html Cynomolgus Monkey oftalmoloogiliste ravimite uurimisel https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79417115.html Translatiivsed ja rist{0}}reaktiivsed uuringud Prisysi immunoloogia ja põletiku NHP mudelitega https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79197713.html Mitte-naiivsed NHP-d prekliinilistes uuringutes: kulu-tõhus lahendus, Prisys Biotech https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/nhp-asthma-model-79197710.html NHP astmamudel: Prekliiniliste ravimite tõhususe uuringute toetamine Prisys Biotechiga https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79197711.html Immunoloogia- ja põletikuuuringute edendamine Cynomolgus Macaques mudelitega - Prisys Biotechnologies https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79197684.html Oligonukleotiidravimite otsene kohaletoimetamine kesknärvisüsteemi ja tavalised histopatoloogilised muutused https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79197706.html Prisys Biotechi intra-tserebrovaskulaarse insuldi (ICH) mudel https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75164836.html Mittekliinilised farmakodünaamika uuringud: SiRNA ravimite väljatöötamise oluline aspekt https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77705049.html MRI-Juhitud suurlooma kesknärvisüsteemi täpne lokaliseerimis- ja kohaletoimetamissüsteem asub Prisys Biotechis https://ee.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://ee.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77059377.html Uuenduslikud lahendused hingamisteede ravi edendamiseks https://ee.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://ee.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74791083.html Prisys: Loomkatsete edendamine Cynomolgus Macaque Studies abil https://ee.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://ee.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76174665.html Prisys saavutas AAALAC Internationali täieliku akrediteeringu: verstapost kõrgete laboriloomade hooldamise standardite tagamisel. https://ee.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://ee.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654981.html Nukleiinhapete teraapia tõstmine uusimate{0}}eeliste abil Prisys Biotechi ahviliste mudelite abil https://ee.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://ee.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74289185.html Revolutsiooniline kesknärvisüsteemi ravimite manustamine: Prisys ja intratekaalse süstimise lubadus https://img01.v15cdn.com/gallery/4x3/148.webp https://ee.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75164835.html Prisys Biotech 2024 1. kvartali uudiskiri - teie usaldusväärne primaatide uuringuspetsialist https://ee.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://ee.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73538908.html Kuidas ultraheli{0}}juhitud maksabiopsia parandab makaaki{1}}põhist uuringut https://ee.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://ee.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73538909.html Juhised ahviliste eluaegseks kasutamiseks biomeditsiinilistes uuringutes: Prisysi biotehnoloogia vaade https://ee.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://ee.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73002331.html Ahvilised: lühike sissejuhatus nende bioloogilistesse omadustesse https://ee.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://ee.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72677624.html Näituse ülevaade|Prisys Biotech särab Ameerika Neuroteaduste Seltsi aastakoosolekul (SfN 2023) https://ee.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://ee.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321728.html Tutvuge Prisys Biotechiga The Society For Neuroscience aastakoosolekul (SfN 2023) https://ee.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://ee.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321726.html Ülemaailmne insuldipäev|Keskenduge isheemilise insuldi loomamudelitele ja farmakoloogiale https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321723.html Prisys Biotech kutsub teid osalema SAPA-Hiina aastakoosolekul 2023. aastal https://ee.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://ee.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321727.html Maailma Alzheimeri tõve päev|AD-ravimite arendamise väljakutsed ja lahendused https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321724.html Prisys Biotechi Cynomolgus Macaque loomamudel aitab välja töötada uusi antikoagulantravimeid https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70964109.html Prisys: uudse XI hüübimisfaktori antikeha BJTJ-1837 kvaliteetse-loomkatseteenuse pakkumine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70964105.html Meetod hüpertriglütserideemia Cynomolgus Monkey mudeli loomiseks ja selle rakendamine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70964108.html Farmakoloogia: peamised parameetrid ja farmakokineetika (PK) tähtsus https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70964106.html Onkolüütilise viiruse ravimite prekliiniline farmakoloogiline hindamine https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/0-70964107.html Kuidas väikesed nukleiinhapperavimid võivad kesknärvisüsteemi haiguste ravi muuta: NHP haiguste mudelite pakkuja Prisys Biotechnology ülevaated https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70964110.html Peptiidravimite farmakokineetika, uurimisstrateegiad ja juhtumiuuringud https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69654382.html ADC Drug PK peamised uurimispunktid https://img01.v15cdn.com/gallery/4x3/148.webp https://ee.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69662364.html Prisys Biotechnology: NHP kesknärvisüsteemi haiguste modelleerimise uurimisplatvormi juht https://ee.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://ee.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309359.html Kuidas GLP-1 toodetega kaalust alla võtta ja diabeeti kontrollida https://ee.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://ee.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309290.html Kuidas Hiina ahv aitab prekliinilisi uuringuid läbi viia? https://ee.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://ee.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309267.html Mis on RNAi efektiivsus? https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309423.html Prisys Biotech Large Animal Experiment Public Service Platform: madal-kulu ja tõhus{1}}lahendus suurloomakatseteks https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69015322.html Kuidas AAV geeniteraapia võib teie nägemust päästa: viimased läbimurded mitte{0}}ahviliste uuringutes https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69015321.html Prisys Biotech esitleb Jaapani toksikoloogiaühingu aastakoosolekul ahviliste mudelite platvormi{0}} https://ee.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://ee.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69015325.html AAV-geeniteraapia paljutõotav tulevik{0}}ahvilistel https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69016433.html Mis on lipiidide nanoosakesed geeniteraapia jaoks? https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69015455.html Prisys Biotech kutsub teid osalema Jaapani Toksikoloogia Seltsi (JSOT) 50. aastakoosolekul https://ee.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://ee.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69021314.html Immunotoksilisuse test, ravimiohutuse hindamine{0}}PRISYS BIOTECH https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68306318.html Isheemilise insuldi optimaalne loommudel, mis on loodud digitaalse lahutamise angiograafia abil{0}}Juhitud autoloogsed trombid Cynomolgus Ahvidel https://ee.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://ee.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68105201.html Miks peaksite hoolima ahvilistest nukleiinhapperavimite manustamissüsteemi uurimis- ja arendustegevuses https://ee.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ee.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68105200.html Kohtuge Prisys Biotechiga 70. JALAS 2023! https://ee.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://ee.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68105203.html Geeniteraapia särab haruldaste haiguste jaoks uute heakskiiduga https://ee.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://ee.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68105199.html Revolutsiooniline uimastite avastamine: kuidas ahvilised optimeerivad SiRNA sõeluuringut kiiremate ja tõhusamate tulemuste saamiseks https://ee.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://ee.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67527643.html SiRNA farmakoloogia efektiivsuse maksimeerimine primaatide uurimisega https://ee.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://ee.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67527642.html Kuidas ahvilised võivad SiRNA-uuringuid muuta: põhjalik juhend https://ee.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://ee.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67527638.html Maailma laboriloomade päeva tähistamine: miks on Prisys pühendunud ahviliste tervise edendamisele https://ee.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://ee.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67527639.html CRISPR/Cas9 uurimise efektiivsuse maksimeerimine ahviliste mudelitega https://ee.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://ee.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67527641.html Terapeutilise potentsiaali vallandamine: miks on nukleiinhapperavimitesse investeerimine meditsiini tulevik https://ee.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://ee.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67527640.html Ahviliste potentsiaali avamine geeniteraapia ravimite sihtmärgi avastamisel https://ee.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://ee.prisysbiotech.com/news/world-parkinsons-disease-day-67527637.html Ühinege Parkinsoni tõve nimel: ühendage käed, et tõsta teadlikkust ülemaailmsel Parkinsoni tõve päeval https://ee.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://ee.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67527636.html Kuidas kasutada ahvilisi tõhusalt geeniteraapia ohutuse hindamisel https://ee.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://ee.prisysbiotech.com/news/gene-therapy-toxicology-66273558.html Geeniteraapia toksikoloogia uuringud Nonhuami primaadiga https://ee.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://ee.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66112682.html Põhjalik juhend geeniteraapia DMPK uuringu läbiviimiseks https://ee.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://ee.prisysbiotech.com/news/gene-therapy-nhp-model-66112678.html Revolutsioonilised meditsiiniuuringud: geeniteraapia läbimurded ahviliste haiguste mudelites! https://ee.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://ee.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66112681.html 10 populaarseimat geeniteraapiaga seotud küsimust https://ee.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://ee.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66112679.html Prisys Biotech: ahviliste farmakoloogia geeniteraapia jaoks https://ee.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://ee.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66112680.html Naiste tervise toetamine: ülevaade endometrioosist https://ee.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://ee.prisysbiotech.com/news/prisys-sot2023-66112675.html PRISYS ja Taichu Group teevad koostööd 2023. aasta SOT-näitusel https://ee.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://ee.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66112677.html Kas vajame valu hindamiseks täiendavaid uuringuid? - NHP https://ee.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://ee.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66112676.html Liituge meiega ülemaailmse looduspäeva tähistamisel https://ee.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://ee.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66112674.html Prisys Shanghai NHP uurimis- ja arenduskeskus käivitab Hiinas farmaatsiauuringute ja -arenduse verstaposti https://ee.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://ee.prisysbiotech.com/news/meetprisys-sot2023-66112673.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://ee.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg